PF
TARO

Phoenix Financial’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Phoenix Financial’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,736
Closed -$200K – 490
2020
Q4 		$200K Buy
+2,736
New +$176K 0.01% 353

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Phoenix Financial's TARO Position: Q1 2021 in Review

Phoenix Financial sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2021, closing a stake of 2,736 shares — an estimated $200K sold.

Phoenix Financial first reported a position in TARO in Q4 2020 and held it in 1 quarter. The position peaked at $200K in Q4 2020. 80 funds tracked by Wall St. Rank hold TARO as of Q1 2021.

  • Phoenix Financial reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2021 after selling out during the quarter.
  • Phoenix Financial sold 2,736 Taro Pharmaceutical Industries Ltd. shares in Q1 2021, an estimated $200K.
  • Phoenix Financial first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2020 and held it in 1 quarter.
  • Phoenix Financial's Taro Pharmaceutical Industries Ltd. position peaked at $200K in Q4 2020.
  • 80 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2021.

Based on Phoenix Financial's 13F filing for Q1 2021, filed 10 May 2021.